Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439100![]() (US10604502, Ex # 88) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439120![]() (US10604502, Ex # 108) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439089![]() (US10604502, Ex # 77) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439014![]() (US10604502, Ex # 2) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439039![]() (US10604502, Ex # 27) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439109![]() (3-(2,2-dimethyl-1,2,3,4-tetrahydroquinolin-5-yl)-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439101![]() (3-(2,2-dimethyl-1,2,3,4-tetrahydro-1,7-naphthyridi...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439046![]() (US10604502, Ex # 34) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439056![]() (US10604502, Ex # 44) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439107![]() (US10604502, Ex # 95) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439121![]() (1-((1R,4R)-1-aminosulfonylcyclohexyl)-6-methyl-3-(...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439090![]() (US10604502, Ex # 78) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439036![]() (3-(3-amino-2-methylphenyl)-1-(3-hydroxypropyl)-2,6...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439015![]() (US10604502, Ex # 3) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439024![]() (US10604502, Ex # 12) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439091![]() (US10604502, Ex # 79) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439122![]() (US10604502, Ex # 110) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439021![]() (US10604502, Ex # 9) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439059![]() (US10604502, Ex # 47) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439124![]() (1-((1R,4R)-4-cyanocyclohexyl)-6-methyl-3-(5-amino-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439123![]() (US10604502, Ex # 111) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439108![]() (US10604502, Ex # 96) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439079![]() (US10604502, Ex # 67) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439092![]() (3-(5-amino-4-chloropyridin-3-yl)-6-methyl-1-(5-(me...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439013![]() (US10604502, Ex # 1) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439041![]() (US10604502, Ex # 29) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439093![]() (US10604502, Ex # 81) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439033![]() (US10604502, Ex # 21) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439077![]() (US10604502, Ex # 65) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439038![]() (US10604502, Ex # 26) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439062![]() (US10604502, Ex # 50) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439094![]() (US10604502, Ex # 82) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439044![]() (US10604502, Ex # 32) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 16 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439080![]() (3(3-(5-amino-4-chloropyridin-3-yl)-5-cyano-6-methy...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 16 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439074![]() (US10604502, Ex # 62) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 16 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439022![]() (US10604502, Ex # 10) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439064![]() (US10604502, Ex # 52) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439069![]() (US10604502, Ex # 57) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439086![]() (US10604502, Ex # 74) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439066![]() (US10604502, Ex # 54) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 23 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439075![]() (US10604502, Ex # 63) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 23 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439026![]() (US10604502, Ex # 14) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 24 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439047![]() (US10604502, Ex # 35) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 25 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439110![]() (US10604502, Ex # 98) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 25 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439057![]() ((1R,4R)-4-(3-(5-amino-4-chloropyridin-3-yl)-5-cyan...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 26 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439016![]() (US10604502, Ex # 15 | US10604502, Ex # 4) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 26 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439016![]() (US10604502, Ex # 15 | US10604502, Ex # 4) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 27 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439023![]() (US10604502, Ex # 11) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 28 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439019![]() (US10604502, Ex # 7) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 28 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439095![]() (US10604502, Ex # 83) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 28 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439040![]() (US10604502, Ex # 28) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 29 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439025![]() (US10604502, Ex # 13) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 30 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439037![]() (3-(5-amino-4-chloropyridin-3-yl)-1-(3-hydroxypropy...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 31 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439078![]() (US10604502, Ex # 66) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 32 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439067![]() (US10604502, Ex # 55) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 33 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439030![]() (3-(3-amino-2-chlorophenyl)-1-(3-hydroxypropyl)-6-m...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 34 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439071![]() (3-(3-(5-amino-4-chloropyridin-3-yl)-5-cyano-6-meth...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 34 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439063![]() (US10604502, Ex # 51) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 37 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439068![]() (3-(5-amino-4-chloropyridin-3-yl)-6-methyl-1-(1-met...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 37 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439072![]() (US10604502, Ex # 60) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 40 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439065![]() (US10604502, Ex # 53) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 40 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439111![]() (US10604502, Ex # 99) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 44 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439096![]() (US10604502, Ex # 84) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 49 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439049![]() (US10604502, Ex # 37) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 52 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439020![]() (US10604502, Ex # 8) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 63 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439087![]() (US10604502, Ex # 75) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 67 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439099![]() (US10604502, Ex # 87) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 67 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439097![]() (US10604502, Ex # 85) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 69 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439088![]() (US10604502, Ex # 76) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 70 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439031![]() (3-(5-amino-4-methylpyridin-3-yl)-1-(3-hydroxypropy...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 71 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439029![]() (3-(3-amino-2-fluorophenyl)-1-(3-hydroxypropyl)-6-m...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 73 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439076![]() (US10604502, Ex # 64) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 77 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439083![]() (US10604502, Ex # 71) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 77 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439084![]() (US10604502, Ex # 72) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 89 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439028![]() (US10604502, Ex # 16) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 94 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439070![]() (US10604502, Ex # 58) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 105 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439073![]() (US10604502, Ex # 61) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 127 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439017![]() (US10604502, Ex # 5) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 135 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439032![]() (US10604502, Ex # 20) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 153 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439112![]() (US10604502, Ex # 100) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 154 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439114![]() (US10604502, Ex # 102) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 154 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439048![]() (US10604502, Ex # 36) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 157 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439061![]() (US10604502, Ex # 49) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 158 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439045![]() (3-(3-amino-2,6-difluorophenyl)-1-(3-hydroxypropyl)...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 162 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439034![]() (US10604502, Ex # 22) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 181 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439113![]() (US10604502, Ex # 101) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 185 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439098![]() (US10604502, Ex # 86) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 188 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439082![]() (US10604502, Ex # 70) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 191 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439043![]() (US10604502, Ex # 31) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 204 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439050![]() (US10604502, Ex # 38) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 206 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439018![]() (US10604502, Ex # 6) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 206 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439053![]() (US10604502, Ex # 41) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 215 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439042![]() (US10604502, Ex # 30) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 243 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439052![]() (US10604502, Ex # 40) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 259 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439051![]() (US10604502, Ex # 39) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 266 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439118![]() (3-(5-amino-4-chloropyridin-3-yl)-2,6-dimethyl-1-(3...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 359 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439054![]() (3-(3-amino-2-cyanophenyl)-1-(3-hydroxypropyl)-6-me...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 365 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439085![]() (US10604502, Ex # 73) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 379 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439081![]() (US10604502, Ex # 69) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 414 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439058![]() ((1R,4R)-4-(3-(5-amino-4-chloropyridin-3-yl)-5-cyan...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 476 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439115![]() (1-((1R,4R)-4-hydroxycyclohexyl)-6-methyl-3-(2-oxo-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 512 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439055![]() (3-(5-amino-4-chloropyridin-3-yl)-1-(1,1-dioxidothi...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 588 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439116![]() (US10604502, Ex # 104) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 776 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439060![]() (US10604502, Ex # 48) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 930 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439102![]() (US10604502, Ex # 90) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 955 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439035![]() (US10604502, Ex # 23) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 1.59E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439117![]() (US10604502, Ex # 105) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 1.94E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439103![]() (US10604502, Ex # 91) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 9.17E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439119![]() (US10604502, Ex # 107) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 9.62E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439104![]() (US10604502, Ex # 92) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 2.21E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439105![]() (US10604502, Ex # 93) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 2.83E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM439106![]() (US10604502, Ex # 94) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | Article US Patent | n/a | n/a | 6.37E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of twelve concentrations. The... | US Patent US10604502 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair |